Share Issue/Capital Change • Aug 10, 2025
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
This is an English translation of a Hebrew immediate report that was published on 7 August, 2025 (reference no.: 2025-01-058569) the abovementioned is hereby incorporated by reference (hereafter: the "Hebrew Version"). This English version has been translated only for the purpose of convenience. It is not an official translation and has no binding force. While reasonable care and skill have been exercised in the preparation hereof, no translation can ever exactly mirror the Hebrew Version. In the event of any discrepancy between the Hebrew Version and this translation, the Hebrew Version shall prevail.

August 7, 2025
To To Israel Securities Authority Tel Aviv Stock Exchange www.isa.gov.il www.tase.co.il
Following the Company's prior Immediate Report1 regarding the focus of its strategic plan, the Company hereby announces that on August 6, 2025, after receiving approval by its Board of Directors, it entered into an Investment Agreement (the "Investment Agreement") with Bercleys Hotels M.G. Ltd., a private company wholly (100%) owned (indirectly) by Mr. Moti Green, which is engaged, directly and via affiliated companies, in real estate development ("the Investor").
Below is a summary of the main terms of the Investment Agreement:
According to the agreement, and subject to the execution of the conditional terms listed below, in exchange for a payment of NIS 30 million, the Company will allocate 115,919,734 ordinary shares2 to the Investor, which will constitute approximately 51% of the issued and paid-up share capital of the Company immediately after allocation.
Additionally, the Company will grant the Investor a PUT Option to sell to the Company the right to use and operate two revenue-generating energy assets (the "Option"): (A) A solar farm – a panoramic rooftop structure made of glass and aluminum, approx. 16,000 sqm, planned for electricity generation and sale to the hotel (located within the same complex), with an estimated capacity of 3–4 MW (the "Solar Farm"); and (B) An EV charging station – at least 2,000 kW
1 Immediate Report dated 31.05.25 (Ref: 2025-01-023967). The above-mentioned are hereby incorporated by reference.
2 In accordance with adjustments that will occur due to consolidation of the Company's capital.

capacity, comprising 30 fast and ultra-fast charging stations for vehicles (the "Charging Station").
The Investor has committed to invest an additional minimum of NIS 20 million in each of the energy assets (i.e., both the Charging Station and the Solar Farm). These are referred to collectively as ("the Revenue-Generating Energy Assets")
and/or employees and/or consultants, in connection with the revenue-generating energy assets. e.) The Investor shall undertake that, if and to the extent that the Company wishes to purchase electricity, it shall be entitled to do so from the Investor, and the Investor shall be obligated to supply electricity to the Company at low-voltage electricity tariff rates prevailing from time to time.
The transaction is conditional upon the following ("Conditional Terms"): a.) Approvals by General Meetings of both parties, including approval of new directors proposed by the Investor for the Company's Board of Directors; approval of the agreement and all terms; approval of Run-Off insurance for all current directors and insurance for incoming directors; approval of the Company's legal right to purchase the energy assets and to sign lease agreements; approval of allocation of shares to the Investor as a Material Private Placement (as defined under Israeli Companies Law 1999 ("Israeli Companies Law") which has been approved by the Company's Board of Directors and approval of which was received from the shareholders in a General Meeting as per Article 328b1 of Israeli Companies Law of a material private placement aimed to grant over 45% of voting rights in the Company. b.) Receipt of TASE approval for listing the shares. ("TASE Approval") c.) Receipt of all necessary regulatory and third-party approvals as required by law. d.) Receipt of nonrevocable consent from Landa Ventures Ltd. for the transaction. e.) Receipt of resignation letters from outgoing directors (effective on deal completion). f.) Delivery of copies of any third-party approvals, if needed, regarding change of control.
It should be clarified that the parties may (but are not obligated) to agree between themselves on waiver of any of the conditions in the event that such conditions are not required by law.
If all conditional terms are not fulfilled within 60 days of signing, ("Final Deadline") either party may cancel the agreement in writing without it being deemed a breach and without
claims or liabilities. Notwithstanding, either of the parties has the right to extend the final deadline by 15 days solely if the extension is needed in order to obtain TASE approval.
Within 15 business days after the Conditional Terms are met, the following activities will be carried out, all of which will be considered to have been carried out in parallel, and no activity will be considered to have been completed until all the activities are completed: ("Closing Date") a.) The Company will provide the Investor with all signed documents required for execution of the share allocation; b.) The Investor will transfer the investment amount, after which the shares will be issued. In addition, within two business days of the Closing Date, lease agreements (conditional upon Option exercise) will be signed by the Company and the Investor.
Upon completion of the transaction, the Board will comprise seven directors, including the two external directors that will serve at the same and five new directors to be appointed (one of whom will be an independent director) names for which are to be proposed by the Investor.
Between signing and closing, the Company has committed to operate only in the ordinary course of business. ("Interim Period") Moreover, the Company has committed not to engage in negotiations or entertain offers inconsistent with the Investment Agreement. A breach of this obligation will be considered material, and violation of such obligation will entitle the Investor to Agreed Compensation without the need to prove damages.
If all Conditional Terms are met by the Closing Date but any party fails to complete the transaction, ("Breaching Party") said party must pay to the other party ("Complying Party") an amount of NIS 6 million as agreed compensation against the damages to the complying party. ("Agreed Compensation").
In light of all the above, the Company will publish an Immediate Report as per the Securities Regulations (Private Placement, 2000; Periodic and Immediate Reports, 1970) (the "Reporting Regulations").
Issuance of shares and publication of the Immediate Report are subject to receipt of all required regulatory approvals, including approval by a the general meeting of the Company's shareholders, approval of listing of allocated shares by the TASE.

Submission of this report was delayed pursuant to Regulation 36(b) of the Reporting Regulations, as its disclosure prior to the signing date could have harmed negotiations of the transaction or adversely impacted its terms. Now that the agreement is signed, the restriction has been lifted.
Respectfully,
.
GenCell Ltd. By: Rami Reshef, CEO
Have a question? We'll get back to you promptly.